Polymer nanoparticles are veritable tools for pharmacokinetic and therapeutic modifications of bioactive compounds. Nanoparticle technology development and scaling up are however often constrained due to poor payload and improper particle dissolution. This work was aimed to develop descriptor based computational models as prior art tools for optimal payload in polymeric nanoparticles. Loading optimization experiments were carried out both in vitro and in-silico. Molecular descriptors generated in three different platforms DRAGON, molecular operating environment (MOE) and VolSurf+ were used. Multiple linear regression analysis (MLR) provided computation models which were further validated based on goodness of fit statistics and correlation coefficients (DRAGON, R 
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The drug discovery process is severely constrained in the current era because of steep rise in R&D expenditure and at the same time only a few practicable chemical entities are being reported. 1) Complexity arising out of drug toxicity and disease management has however remained unabated. Discovery process therefore has seen a paradigm shift in favor of pharmacokinetic modulation of known chemical entities rather than pharmacodynamic developments.
2) A search in favor of purified plant products has also been renewed because of inherent low toxicity and easier availability.
3) Of late, rapid developments in nanomedicines as platform technology have provided further scope in pharmacokinetic modulations of known chemical entities. Polymer associated nanoparticle engineering is known to enable drug molecules remain longer in systemic circulation or help target them to cellular sites. Modulations of size, charge and surface chemistry are known to assist in such effects. 4) Enhanced kinetic targeting is passable for nanomedicines particularly in tumors or in sites of inflammation. 5, 6) Remarkable success in such therapy have already been achieved with polymeric nanoparticles. 7) Despite many advantages polymeric nanoparticles are faced with overwhelming challenges in preparative stages. 8) Preparation of polymeric nanomedicines requires multiple trial and error runs leading to high cost and loss of precious drug molecules. Specific successes are often unpredictable and up-scaling practices difficult. Drug loading is generally unpredictable in all cases including known chemical entities and plant drug molecules. Diverse physicochemical interactions are considered as determinants in successful polymeric nanoparticle drug loading. 9) Quantitative structure performance relationship (QSPR) tools have earlier been used in drug discovery and chemical toxicology. 10, 11) Modeling tools for accurate assessment of physicochemical properties and molecular interactions were known in pharmaceutics. 12, 13) Application of in-silico tools in nanomedicine developments is relatively recent. Costache et al. have used modeling tools to understand drug polymer interactions in polyethylene glycol (PEG)-tyrosine copolymer nanospheres. 14) One interesting recent study has used descriptor based modeling tools for nanostructure biological property relationships studies. 15) Simulation tools were very recently experimented in design of targetable nanoparticles 16) and an excellent review to extrapolate QSPR techniques as a predictive tool for nanomaterial properties has just been published. 17) Herein, we intend to develop and evaluate in-silico models as prior art tools for nanoparticle payload predictions. Poly(dllactide-co-glycolic acid) (PLGA) was taken as the polymer material. PLGA is the most widely used polymer for nanoparticle drug delivery and is also approved by U.S. Food and Drug Administration (FDA). 18) Descriptor based tools were used to work out the fundamental relations responsible for successful molecular payload. Physicochemical interactions that are important in drug loading were further studied following probe mapping techniques. Parallel in vitro experiment was followed with known chemical entities that associate biopharmaceutical limitations. Computational design of nanoparticle drug delivery devices is seen as a substantial solution and prior-hand tool particularly for selection of loadable molecules and polymeric materials.
Experimental
Materials Silybin (Sb), Polyvinyl alcohol (PVA), PLGA (50 : 50, molecular weight (MW) 40000-75000), and dialysis tubing D9652 (MW cut off 12400) were purchased from Sigma Aldrich (St. Louis, MO, U.S.A.) and Andrographolide (AG) was from Natural Remedies (Bangalore, India). All solvents and water used in in vitro experiments were HPLC grade and were purchased from E. Merck or Spectrochem Nanoparticle Preparation Emulsion and solvent evaporation technique was followed throughout keeping all parameters constant except the loadable compound Sb or AG. Nanoparticle preparation process was as detailed by us elsewhere. 19) Initial mass ratio for PLGA polymer and the loadable drug was also kept constant. Briefly, PLGA was dissolved in organic phase alongside AG or Sb and the organic phase was emulsified under sonication (20 kHz, 750 w) for one minute in an aqueous solution containing 4% w/v PVA. The resultant oil/water emulsion was further homogenized at 30000 rpm for 1 h under external cooling in ice water. The solvent evaporation was continued for 12 h over a magnetic stirrer at room temperature and nanoparticles (AGnp or Sbnp) were harvested by ultracentrifugation at 30000 rpm for 30 min at 4°C. These were washed in water, re-centrifuged and preserved in vacuum desiccators at 4°C until further evaluations.
Nanoparticle Characterization Nanoparticles (AGnp, Sbnp) were characterized for their particle size, poly dispersity index (PDI) and zeta potential in Zetasizer nano ZS. Particle size was measured against a 4mw He-Ne laser beam 633 nm, and back scattering angle of 173° and the PDI was also recorded. Zeta potential was determined on the basis of electrophoretic mobility under an electrical field using Smoluchosky equation. The morphology examination of the nanoparticles of both AGnp and Sbnp types were carried out under an atomic force microscope in tapping mode using RTESP tip at 267-328 kHz resonance frequency and a scan speed of 1.2 Hz.
Nanoparticle Loading AG was analysed at 228 nm in a HPLC set up. The mobile phase for analysis was acetonitrile-0.1% (v/v) phosphoric acid in water (40 : 60, v/v), flow rate 1 mL/min. 19) A peak area (y) vs. concentration (x) graph was first drawn from different known concentrations of AG. Analyte mass originally taken and that in supernatant after nanoparticles preparation were determined separately from the HPLC peak area observations.
In case of Sb the HPLC PDA detector (2996, Waters, U.S.A.) was set at 288 nm and a mixture of 85% phosphoric acid-methanol-water (0.5 : 46 : 64, v/v) was used as the mobile phase. 20) The solvent flow rate was 1 mL/min. Both analysis were carried out using C 18 column (Supelco, Bellefonte, PA, U.S.A.), 25×4.6 mm.
Percentage drug loading was determined from triplicate experiments and were represented as molecular loading (%) mass of drug originally taken mass of drug in supernatant mass of drug originally taken
Computational Study Compiling a diverse molecular datasets with known mass loading was complex due to varied polymer choices, different experimental conditions used and also the preferences in reporting mass loading. Manual, textbased searches were undertaken from a range of data source including PubMed, Web of Sciences, ACS, Scopus, Science Direct and Wiley Publication Resource Centers under institutional subscriptions. Logarithmic form (log 10 ) of percentage mass loading was used as the response parameter. A dataset of 22 compounds was build based on literature survey and our laboratory experiments. The assimilated data set was randomly divided into training set (Tr) and test set (Ts) for modeling and validation studies. ChemDraw, was initially used to generate the 2-dimensional (2-D) structures of the molecules and further 3-D structures were generated for inspections using Chem3DUltra (Chem Office 2002 version 7.0, U.S.A.). Molecular geometries were optimized in MOPAC (MOPAC 2000 version 7.0, U.S.A.) using AM1 semi empirical method and used further for computation of different model descriptors.
Descriptors One objective of this study was to capture the most informative descriptors set and finally develop a hypothesis for high drug mass loading in PLGA nanoparticles. Three independent microscopic descriptor machines namely DRAGON, molecular operating environment (MOE) and VolSurf+ were used throughout.
DRAGON Descriptors: All 0D, 1D, 2D and 3D descriptors generated by DRAGON software (DRAGON version 5.5, U.S.A.) were explored to accommodate wider variety of types. 0D descriptors provided the molecular constitutional propertis, 21) 1D descriptors provided functional group counts and atom-centered fragments, 22) 2D descriptors extended topological descriptors, connectivity indices and eigen value based indices 23) and 3D descriptors provided different molecular geometry functionalities. [24] [25] [26] [27] A total of 1504 number of descriptors were generated through DRAGON. Descriptors with invalid values, with too many zeros and with small standard deviation (less than 0.5) were rejected in further applications.
MOE Descriptors: Two classes of molecular descriptors, namely 2D and 3D molecular descriptors ("i3D" internal coordinate dependent and "x3D" external coordinate dependent) were calculated using the molecular operating environment modeling program (MOE version 2007.09, Canada). The 2D molecular descriptors are the numerical properties evaluated from the connection tables representing a molecule and include physical properties, subdivided surface areas, atom counts, bond counts, Kier and Hall connectivity 28) and κ shape indices, 29, 30) adjacency and distance matrix descriptors containing BCUT and GCUT descriptors, [31] [32] [33] [34] [35] pharmacophore feature descriptors, and partial charge descriptors (PEOE descriptors). 36 ) Different 3D descriptors 37) include a number of quantum chemical descriptors, such as the molecular dipole moments, heat of formation, ionization potentials, highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) energies calculated using the AM1 semi-empirical method. The total number of MOE descriptors finally considered was 201.
VolSurf+ Descriptors: VolSurf+ descriptors were calculated using VolSurf+ (VolSurf+ version 1.0.4, U.K.) in windows platform. VolSurf+ was used to generate 2D molecular descriptors from 3D molecular interaction energy grid maps. 38) The basic idea in VolSurf+ is to compress the information present in 3D maps into well defined 2D numerals. These descriptors quantitatively characterize the size, shape, polarity and the hydrophobicity of molecules. GRID probes used in the calculation of the VolSurf+ descriptors were, the water probe (OH2), the hydrophobic probe (DRY), the carbonyl oxygen atom probe (O) and amide probe (N1). Grid spacing was set to 0.5 Å and a total 128 descriptors were derived for further applications.
Multiple Linear Regression (MLR) Analysis Linear correlation models were derived through standard and forward stepwise regression techniques in STATISTICA (Statistica version 7.1, U.S.A.). Descriptor inter-correlations were further cross checked and the final MLR equation was developed accommodating only the principle non-correlated descriptors. All data were statistically analyzed through computation of R 2 (correlation coefficient), F (variance ratio) with df (degrees of freedom), s (standard error of estimate). The final selected model was cross-validated through leave-one-out (LOO) technique 39) applying Press av (average of absolute value of predicted residuals), SDEP (standard deviation of error of predictions) and Q 2 (cross-validated variance) as model validation tools. The analysis was performed in HP xw6600 work station with 4GB RAM and 1TB hard disk.
Space Modeling CATALYST 40) (CATALYST version 4.11, U.S.A.) was used to understand the fundamental molecular forces important for molecular payload in polymeric particles. A pharmacophore model consists of a 3D arrangement of a collection of chemical features necessary for the activity of the ligands. The input chemical features considered for this study were hydrogen bond (HB) acceptor (a) and donor (d), hydrophobic (p), and ring aromatic (r). Different control parameters used for hypothesis generation were spacing, uncertainty and weight variation. Spacing represented the minimum inter-features distance that may be allowed in the resulting hypothesis. Each parameter in the generated hypothesis implies an order of magnitude of the compound's activity. The level to which it is explored by the hypothesis generator is controlled by the weight variation parameter. The uncertainty parameter reflects the degree of confidence and tolerance factor of the biological data. Compounds were subjected to internal strain energy minimization and conformational analysis. The costs of null and fixed hypotheses were calculated. A greater difference between the fixed and the null costs is an indicator for lower chance correlations. The minimum difference between the total and null costs was taken as 60 bits for hypothesis optimization. The quality of hypothesis was further adjudged through a cross-validation technique using CatScramble based on Fischer's randomization test, where the activity data were randomized within a fixed chemical data set.
In-Vitro Release and Modeling Payload release and release kinetic modeling were studied for prepared nanoparticles in order to relocate the loaded molecules. AGnp and Sbnp equivalent to 2 mg of AG and Sb payload were suspended in 1 mL of phosphate buffer (100 mm, pH 7.4) and transferred separately in dialysis bags. The dialysis bags were then placed in glass vials containing 10 mL phosphate buffer. Both were kept in an incubator shaker at 37°C and 50 rpm. At predetermined time intervals, 5 mL of release medium were withdrawn for analysis. Withdrawn samples were compensated by fresh buffer to maintain the sink condition. The amount of AG and Sb released per timed sample were estimated in HPLC method with necessary corrections for the dilution factors. The in-vitro release studies for all preparations were completed in triplicate and the cumulative percentage release over time was plotted.
Results and Discussion
PLGA Nanoparticles A generalised emulsion and solvent evaporation technique was followed throughout for nanoparticulation and the final particle characteristics were listed in Table 1 . Nanoparticle loading percentage and the zeta potentials are influenced by the polymer characteristics and the loadable molecule used. 41 ) Drug loading and the particle surface charge were different in case of AGnp and Sbnp due to varied polymer payload and physicochemical interactions. Both Sb and AG are hydrophobic compounds and have a close proximity in solubility characteristics. Large differences in nanoparticles loading percentage indicated that solubility factors are not the only parameters responsible for higher mass loading in PLGA nanoparticles. Uniform surface morphology is a characteristic for PLGA nanoparticles. Both AGnp and Sbnp appeared spherical and of smooth surface when studied under atomic force microscope (Fig. 1) .
Effectiveness of a drug delivery device is directly dependent on its drug payload. A superior molecular mass payload at the preparative stages not only reduces loss but can also extend a more effective delivery device. The mass payload in nanoparticles was determined in HPLC by measuring the amount of drug originally taken and the mass of nonentrapped drug present in the supernatant accumulated after centrifugation and washings. The standard graph equation for (Table 1) . This was considered possible due to multiple molecular interactions during formation of loaded nanoparticles. Zeta potential of nanoparticles was negative due to biopolymer PLGA but was widely different in both cases. In-Silico Studies One objective of this work was to generate a relationship between the structural parameters and their corresponding mass payload in designated biopolymer PLGA. In-silico model was developed to understand, correlate and foretell payload in nanoparticles. Descriptor based MLR approach perfected in molecular modeling and drug design was used as a platform technology. 42) A survey through different literature sources revealed a range of drug loaded polymeric nanoparticles varying in process technology and selection of polymer types. PLGA 50 : 50 is however the only polymer approved by U.S. FDA for nanomedicine applications so far. Working data set was selected based on the uniformity of nanoparticle process technology and the polymer choice PLGA.
Altogether 22 compounds reported in literature [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] including those reported from our laboratory were used for generation of analysis models (Table 2 ). Percentage mass loading was considered the property and used in logarithmic form. Enlisted compounds (Table 2 ) provided a wide range of chemical structures and a range of drug mass load in PLGA. These were used to develop minimum energy charge neutralized conformers for further studies. Molecular and atomic descriptors were generated separately on DRAGON, MOE and VolSurf+ platform.
The DRAGON platform developed a 22×1504 matrix while MOE platform provided a 22×201 matrix and VolSurf+ provided a 22×128 matrix. Each matrix was fitted for a MLR equation in STATISTICA. The final reduced model was cross validated in each case and similar findings were reported elsewhere. 42, 60, 61) Descriptor inter-correlations were cross checked and the final MLR equations were developed accommodating only the non-correlated descriptors. The best linear QSPR models for drug loading in PLGA in three different descriptor platform were depicted in Table 3 . Log of percentage mass loading represented as log 10 A. Statistical significance of each regression equation was evaluated by the statistical parameters like R 2 and F. The predictive power of the model was judged from Q 2 values, SDEP and PRESS avg through LOO method. Each model was again validated through a test set estimation of R 2 pred and the statistical qualities of models were presented in Table 4 .
Among 1504 DRAGON descriptors after several permutations the optimum model generated with five descriptors (Table 3) where Mor29u is derived from infrared spectra simulation and represented the 3D structure of a molecule by a fixed number of variables irrespective of number of atoms in the molecule. GATS5m is a distance type function. C-019 is among the atom-centered fragments where atom types were classified in relation to their structural environment. T(N…O) depicted the topological features of the atom which described the compound similarities in a quantitative manner. MATS2m is the spatial autocorrelation molecular descriptor, related to the atomic property like atomic mass. 62) The selected descriptors in the final model generated with MOE descriptor were E_strain, Reactive, SMR_VSA4, SMR_VSA7 and MNDO_HF. E_strain is among the potential energy descriptors which signifies the non-covalent interaction potential energy accountable for the loading affinity of the drug to the considered polymer. Reactive is related to the molecular property, SMR_VSA4, SMR_VSA7 are the descriptors based on approximate accessible van der Waals surface area calculation for each atom along with molar refractivity. MNDO_HF is related to heat of formation. 62) In VolSurf+ LgS10 indicates the importance of solubility parameter of drug molecule at pH10, WO6 is the hydrogen bond donor descriptor computed at 6 kcal/mol energy level. DD4 denotes the difference between the maximum hydrophobic volume and the hydrophobic volume of the 3D structure of the drug molecule. DRACAC is the 3D pharmacophoric descriptor based on the triplets of pharmacophoric point descriptor.
The independent variables used in these 2D QSPR models were not inter-correlated (R<0.5). The observed vs. predicted mass loading (logarithmic form) as per DRAGON, MOE and VolSurf+ model were presented in Fig. 2 .
Pharmacophore Space Modeling Study In order to further understand the specific payload polymer interactions in PLGA nanoparticles, a receptor independent space modeling study was performed with the dataset using hypogen algorithm of CATALYST. The best hypothesis was derived on the basis of highest cost difference (Δcost=108.931), low root mean square division (rmsd=1.203) and the best correlation (R 2 =0.882). The mapped pharmacophoric features adjudicated were hydrogen bond acceptor in three different zones and one hydrophobic feature in 3D space. The quality of the hypothesis generated was further decided through a cross-validation technique using Fischer's randomization test at 95% confidence, where the activity (Y-randomization) data were randomized within the chemical data set and the hypogen process was initiated to explore possibilities of other hypothesis of predictive values. Further the value of total cost of the model 96.625 was closer to the fixed cost of 80.363, which further suggested closeness to the ideal hypothesis. The critical inter feature distance imparting drug loading in PLGA in 3D space were depicted in Fig. 3 . The most active compound of the test set mapped all the features in the model hypothesis.
In-silico predictive mass loading for AG in PLGA was higher among the test compounds while that in case of Sb was much lower. These observations correlated well with the in vitro experiments for Sb and AG mass loading in PLGA nanoparticles. In-silico modeling therefore can extend a reasonable tool for selection of drug and polymer in design of nanoparticle drug delivery devices in the preformulation stages itself.
In-Vitro Drug Release and Modeling Studies Release studies of hydrophobic bioactives from polymeric nanodevices often encounter a number of challenges. 63) Solubility of AG in water at 37°C is 3 µg/mL and that for Sb was 0.4 mg/mL. However solubility alone may not be the determinants for success in nanoparticle drug loading and release kinetics. Dissolution and in vitro release was studied in dialysis bags and molecular leaching was retraced in HPLC experiments. Initial drug release pattern from both AGnp and Sbnp displayed significant burst effect due to surface adsorbed molecules in PLGA nanoparticles. The later part of the release was attributed to chain scission and hydrolytic erosion of the PLGA matrix. 64) Amount of drug entrapped in nanoparticles often affect the release characteristics. 65) AGnp released 37% of payload in 24 h as compared to 24% release in case of Sbnp over the same time period. AGnp displayed a sustained release pattern up to 720 h and 80% of the payload could be accounted in the study period (Fig. 4) .
Korsemeyer-Peppas model (Eq. 1) was used to describe the drug release mechanism from nanoparticles over a time range.
where M t , mass released at time point 't,' M α , total mass load, n is the release exponent and K is the constant accommodating the structural and geometrical features. The n and k value recorded for both AGnp and Sbnp were represented in Table  5 . The n values near 0.3 indicating that the release mechanism was not a fickian diffusion. 67) Similar observations were reported earlier as a result of simultaneous PLGA polymer disintegration.
19)

Conclusion
Descriptor based QSPR models were developed for prediction of drug payload in PLGA nanoparticles. Molecules expressing strong hydrogen bond acceptors, ring aromatic features and a distance geometry are predictable for higher percentage nanoparticle payload in PLGA biopolymer. The success of models generated was marked by oneness of the results. Parallel in vitro synthesis for AG and Sb in PLGA corroborated well with the in-silico results. New descriptor based QSPR model will be a beneficial tool in polymeric nanoparticle synthesis. 
